Assembly Biosciences, Inc.
ASMBNasdaqCIK 1426800HealthcareFiscal year ends Dec 31
Reports and events: 287 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1416:05 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-352193 |
| 2026-08-1316:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-349236 |
| 2026-08-1316:11 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-349198 |
| 2026-06-0516:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-259481 |
| 2026-05-2616:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-239277 |
| 2026-05-2207:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-235469 |
| 2026-05-0716:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211987 |
| 2026-05-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211922 |
| 2026-04-2216:12 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001193125-26-170417 |
| 2026-03-3017:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-131872 |
| 2026-03-1916:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-115992 |
| 2026-03-1916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-115980 |
| 2025-12-0816:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-311251 |
| 2025-11-1016:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274277 |
| 2025-11-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274235 |
| 2025-08-1117:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-178092 |
| 2025-08-0808:24 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-176138 |
| 2025-08-0616:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104060 |
| 2025-08-0616:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-104020 |
| 2025-06-2516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-089949 |
| 2025-06-0917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-083830 |
| 2025-05-0816:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066991 |
| 2025-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066946 |
| 2025-04-2316:10 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0000950170-25-057353 |
| 2025-03-2016:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-042673 |
| 2025-03-2016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-042660 |
| 2025-02-2016:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-024134 |
| 2025-01-0316:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-25-001141 |
| 2024-12-2608:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-139962 |
| 2024-12-1908:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-24-138242 |
| 2024-12-1316:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-24-136183 |
| 2024-11-0716:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-123466 |
| 2024-11-0716:24 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123402 |
| 2024-11-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123355 |
| 2024-09-2308:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-108629 |
| 2024-08-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093998 |
| 2024-08-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093946 |
| 2024-06-2416:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001079973-24-000954 |
| 2024-06-1816:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-24-163398 |
| 2024-06-0316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-067951 |
| 2024-05-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055680 |
| 2024-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055650 |
| 2024-04-1716:10 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0000950170-24-045105 |
| 2024-03-2816:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-038057 |
| 2024-03-2816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-038044 |
| 2024-03-1516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-032162 |
| 2024-02-1316:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-014534 |
| 2024-02-0216:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0000950170-24-010475 |
| 2024-01-1716:05 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-24-005024 |
| 2023-12-2116:01 ET | DEF 14A | Proxy statementPeriod 2024-01-31 | 0001193125-23-301174 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.